PRIME GRANT

U01HL146002

Cooperative Agreement

Overview

Awardee
Brigham & Womens Hospital
Grant Description
Immunometabolic phenotypes in adult severe asthma and disease progression.
Grant Program (CFDA)
93.837 - Cardiovascular Diseases Research
Awarding / Funding Agency
National Heart Lung and Blood Institute (NHLBI) [HHS - NIH]
Place of Performance
Boston, Massachusetts 02115 United States
Geographic Scope
Single Zip Code
Related Opportunity
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) (PA-18-484)
Notes
COVID-19 $434,002 (3%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Amendment Since initial award the total obligations have increased 405% from $3,419,613 to $17,276,351.
Brigham & Womens Hospital was awarded Immunometabolic phenotypes in adult severe asthma and disease progression Cooperative Agreement U01HL146002 worth $17,276,351 from National Heart Lung and Blood Institute in September 2019. The grant has a duration of 4 years 9 months and was awarded through assistance program 93.837 Cardiovascular Diseases Research.

Status
(Ongoing)

Last Modified 8/21/23

Period of Performance
9/23/19
Start Date
6/30/24
End Date
84.0% Complete

Funding Split
$17.3M
Federal Obligation
$0.0
Non-Federal Obligation
$17.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Subgrant Awards

Disclosed subgrants for U01HL146002

Transaction History

Modifications to U01HL146002

Additional Detail

Award ID FAIN
U01HL146002
SAI Number
U01HL146002-1702802808
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Funding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Performance District
MA-MA-07
Senators
Edward Markey
Elizabeth Warren
Modified: 8/21/23